Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition

被引:42
作者
Bostrom, Anna-Karin [1 ]
Moller, Christina [1 ]
Nilsson, Elise [1 ]
Elfving, Peter [2 ]
Axelson, Hakan [1 ]
Johansson, Martin E. [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden
[2] Skane Univ Hosp, Dept Urol, SE-20502 Malmo, Sweden
关键词
Clear cell renal cell carcinoma; Epithelial-to-mesenchymal transition; Sarcomatoid renal cell carcinoma; GROWTH-FACTOR-BETA; TGF-BETA; CANCER; EXPRESSION; KIDNEY; TUMORS; DIFFERENTIATION; CLASSIFICATION; MECHANISMS; RECEPTORS;
D O I
10.1016/j.humpath.2011.06.019
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Approximately 8% of clear cell renal cell carcinoma cases contain regions of radically different morphology, demonstrating a mesenchymal appearance histologically resembling sarcomas. These biphasic neoplasms are called sarcomatoid clear cell renal cell carcinoma. Patients diagnosed with sarcomatoid clear cell renal cell carcinoma face a considerably worse prognosis due to an increased propensity for metastasis. In the present study we investigate whether the sarcomatoid conversion of clear cell renal cell carcinoma could be interpreted as linked to the process of epithelial-mesenchymal transition. Using 6 biphasic clear cell renal cell carcinoma cases we show that sarcomatoid clear cell renal cell carcinoma shares characteristic markers associated with loss of von Hippel-Lindau tumor suppressor with conventional clear cell renal cell carcinoma and also exhibits a markedly higher proliferative index. Furthermore the sarcomatoid elements demonstrate an enhanced expression of epithelial-mesenchymal transition related mesenchymal markers as compared with the clear cell renal cell carcinoma counterparts. We further selected a representative case, clinically demonstrating direct overgrowth of the sarcomatoid component into the liver and colon, for extended immunohistochemical characterization, resulting in a further set of positive and negative epithelial-mesenchymal transition markers as well as pronounced transforming growth factor beta positivity, indicating that sarcomatoid clear cell renal cell carcinoma may be associated to epithelial-mesenchymal transition. Transforming growth factor beta 1 exposure of in vitro cultured primary clear cell renal cell carcinoma cells resulted in cells adopting a mesenchymal morphology similar to sarcomatoid clear cell renal cell carcinoma. Corresponding changes in RNA levels for key epithelial-mesenchymal transition markers were also seen. We therefore suggest that sarcomatoid clear cell renal cell carcinoma morphologically and immunohistochemically may represent a completed epithelial-mesenchymal transition and that transforming growth factor beta 1 could be an important driving force during the sarcomatoid transdifferentiation of clear cell renal cell carcinoma. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:708 / 719
页数:12
相关论文
共 36 条
[1]   Markers of epithelial-mesenchymal transition and epithelial differentiation in sarcomatoid carcinoma: Utility in the differential diagnosis with sarcoma [J].
Cates, Justin M. M. ;
Dupont, William D. ;
Barnes, Jason W. ;
Edmunds, Hayward S. ;
Fasig, John H. ;
Olson, Sandra J. ;
Black, Candice C. .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (03) :251-262
[2]   Sarcomatoid differentiation in renal cell carcinoma - A study of 101 cases [J].
de Peralta-Venturina, M ;
Moch, H ;
Amin, M ;
Tamboli, P ;
Hailemariam, S ;
Mihatsch, M ;
Javidan, J ;
Stricker, H ;
Ro, JY ;
Amin, MB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (03) :275-284
[3]   Sarcomatoid renal carcinoma: The final common dedifferentiation pathway of renal epithelial malignancies [J].
Delahunt, B .
PATHOLOGY, 1999, 31 (03) :185-190
[4]   PROGNOSTIC-SIGNIFICANCE OF KI-67 IMMUNOSTAINING IN NONMETASTATIC RENAL-CELL CARCINOMA [J].
DERIESE, WTW ;
CRABTREE, WN ;
ALLHOFF, EP ;
WERNER, M ;
LIEDKE, S ;
LENIS, G ;
ATZPODIEN, J ;
KIRCHNER, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1804-1808
[5]  
EBERT T, 1990, CANCER RES, V50, P5531
[6]   Divergent expression patterns for hypoxia-inducible factor-1β and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney [J].
Freeburg, PB ;
Abrahamson, DR .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (10) :2569-+
[7]   Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy [J].
Golshayan, Ali Reza ;
George, Saby ;
Heng, Daniel Y. ;
Elson, Paul ;
Wood, Laura S. ;
Mekhail, Tarek M. ;
Garcia, Jorge A. ;
Aydin, Hakan ;
Zhou, Ming ;
Bukowski, Ronald M. ;
Rini, Brian I. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) :235-241
[8]   PRIMARY BIOASSAY OF HUMAN TUMOR STEM-CELLS [J].
HAMBURGER, AW ;
SALMON, SE .
SCIENCE, 1977, 197 (4302) :461-463
[9]   Distinct mechanisms of TGF-β1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis [J].
Han, G ;
Lu, SL ;
Li, AG ;
He, W ;
Corless, CL ;
Kulesz-Martin, M ;
Wang, XJ .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1714-1723
[10]   Cancer statistics, 2004 [J].
Jemal, A ;
Tiwari, RC ;
Murray, T ;
Ghafoor, A ;
Samuels, A ;
Ward, E ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29